These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 1658183)

  • 1. Angiotensin-converting enzyme inhibition and physical training in heart failure.
    Meyer TE; Casadei B; Coats AJ; Davey PP; Adamopoulos S; Radaelli A; Conway J
    J Intern Med; 1991 Nov; 230(5):407-13. PubMed ID: 1658183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo-controlled study of lisinopril in congestive heart failure: a multicentre study.
    Chalmers JP; West MJ; Cyran J; De La Torre D; Englert M; Kramar M; Lewis GR; Maranhao MF; Myburgh DP; Schuster P
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S89-97. PubMed ID: 2442560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group.
    Giles TD; Katz R; Sullivan JM; Wolfson P; Haugland M; Kirlin P; Powers E; Rich S; Hackshaw B; Chiaramida A
    J Am Coll Cardiol; 1989 May; 13(6):1240-7. PubMed ID: 2539403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of treatment with lisinopril versus enalapril for congestive heart failure.
    Zannad F; van den Broek SA; Bory M
    Am J Cardiol; 1992 Oct; 70(10):78C-83C. PubMed ID: 1329478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of lisinopril versus placebo for congestive heart failure.
    Lewis GR
    Am J Cardiol; 1989 Feb; 63(8):12D-16D. PubMed ID: 2537560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparison of lisinopril with captopril in patients with symptomatic congestive heart failure.
    Powers ER; Chiaramida A; DeMaria AN; Giles TD; Hackshaw B; Hart W; Haugland M; Johnston R; Katz R; Kirlin P
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S82-8. PubMed ID: 2442559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
    Giles TD; Fisher MB; Rush JE
    Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction.
    Patten RD; Kronenberg MW; Benedict CR; Udelson JE; Kinan D; Stewart D; Yusuf S; Smith JJ; Kilcoyne L; Dolan N; Edens TR; Metherall J; Konstam MA
    Am Heart J; 1997 Jul; 134(1):37-43. PubMed ID: 9266781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lisinopril in the treatment of congestive heart failure.
    Giles TD
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():83-7. PubMed ID: 2550647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with lisinopril in congestive heart failure. Focus on the older patient.
    Giles TD
    Drugs; 1990; 39 Suppl 2():17-22. PubMed ID: 2160883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors, left ventricular dysfunction, and early heart failure.
    Cleland JG; Shah D; Krikler S; Frost G; Oakley CM
    Am J Cardiol; 1992 Oct; 70(10):55C-61C. PubMed ID: 1329475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different hemodynamic (24-h ambulatory blood pressure monitoring) and renin-inhibiting effect of a 1-week treatment with enalapril and lisinopril.
    Cocco G; Hari J
    Clin Cardiol; 1991 Nov; 14(11):881-4. PubMed ID: 1662562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of single doses of lisinopril and enalapril in hypertension.
    Dews I; Wiseman WT; al-Khawaja I; Stephens J; VandenBurg M
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():35-9. PubMed ID: 2550644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive effect of lisinopril assessed by 24-hour ambulatory monitoring: a double-blind, placebo-controlled, cross-over study.
    Tomei R; Rossi L; Carbonieri E; Franceschini L; Molon G; Zardini P
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):911-4. PubMed ID: 1376812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of lisinopril on serum catecholamine concentrations both at rest and on exercise in patients with congestive cardiac failure. A double blind, placebo controlled, parallel group study.
    Fahy G; Deb B; Robinson K; Graham I
    Ir Med J; 1993; 86(4):134-5. PubMed ID: 8395488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lisinopril versus placebo in older congestive heart failure patients.
    Lewis GR
    Am J Med; 1988 Sep; 85(3B):48-54. PubMed ID: 2844088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-dose blood pressure response in mild-to-moderate heart failure: a randomized, double-blind study comparing enalapril with lisinopril by 24-hour noninvasive blood pressure monitoring.
    Otterstad JE; Froeland G
    Am J Cardiol; 1992 Oct; 70(10):132C-134C. PubMed ID: 1329468
    [No Abstract]   [Full Text] [Related]  

  • 18. Lisinopril dose-response relationship in essential hypertension.
    Gomez HJ; Cirillo VJ; Sromovsky JA; Otterbein ES; Shaw WC; Rush JE; Chrysant SG; Gradman AH; Leon AS; MacCarthy EP
    Br J Clin Pharmacol; 1989 Oct; 28(4):415-20. PubMed ID: 2556172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses.
    Uretsky BF; Shaver JA; Liang CS; Amin D; Shah PK; Levine TB; Walinsky P; LeJemtel T; Linnemeier T; Rush JE
    Am Heart J; 1988 Aug; 116(2 Pt 1):480-8. PubMed ID: 2840815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lisinopril: dose-peak effect relationship in essential hypertension.
    Cirillo VJ; Gomez HJ; Salonen J; Salonen R; Rissanen V; Bolognese JA; Nyberg R; Kristianson K
    Br J Clin Pharmacol; 1988 May; 25(5):533-8. PubMed ID: 2841960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.